Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$23.04
0.974.40%
At close: -
$22.69
-0.35-1.52%
After Hours: 8:32 AM EDT
Comments
Loading...
Palvella Therapeutics Analyst Ratings and Price Targets | NASDAQ:PVLA | Benzinga
Palvella Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Palvella Therapeutics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Chardan Capital
Stifel
Jones Trading
Scotiabank
1calculated from analyst ratings
Analyst Ratings for Palvella Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/30/2025 | Buy Now | — | HC Wainwright & Co. | Andrew Fein54% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 04/09/2025 | Buy Now | — | Chardan Capital | Geulah Livshits45% | → $50 | Initiates | → Buy | Get Alert |
| 04/01/2025 | Buy Now | — | HC Wainwright & Co. | Andrew Fein54% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 03/26/2025 | Buy Now | — | Stifel | Annabel Samimy70% | → $45 | Initiates | → Buy | Get Alert |
| 03/25/2025 | Buy Now | — | Jones Trading | Catherine Novack32% | → $45 | Initiates | → Buy | Get Alert |
| 03/07/2025 | Buy Now | — | Scotiabank | Louise Chen54% | → $50 | Initiates | → Sector Outperform | Get Alert |
| 02/26/2025 | Buy Now | — | Canaccord Genuity | Whitney Ijem54% | $39 → $39 | Maintains | Buy | Get Alert |
| 02/20/2025 | Buy Now | — | Canaccord Genuity | Whitney Ijem54% | → $39 | Initiates | → Buy | Get Alert |
| 02/11/2025 | Buy Now | — | HC Wainwright & Co. | Andrew Fein54% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 02/05/2025 | Buy Now | — | TD Cowen | Ritu Baral28% | → $44 | Initiates | → Buy | Get Alert |
| 01/10/2025 | Buy Now | — | HC Wainwright & Co. | Andrew Fein54% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 01/03/2025 | Buy Now | — | HC Wainwright & Co. | Andrew Fein54% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 12/26/2024 | Buy Now | — | HC Wainwright & Co. | Andrew Fein54% | → $38 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Palvella Therapeutics (PVLA) stock?
The latest price target for Palvella Therapeutics (NASDAQ:PVLA) was reported by HC Wainwright & Co. on April 30, 2025. The analyst firm set a price target for $38.00 expecting PVLA to rise to within 12 months (a possible 67.47% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Palvella Therapeutics (PVLA)?
The latest analyst rating for Palvella Therapeutics (NASDAQ:PVLA) was provided by HC Wainwright & Co., and Palvella Therapeutics reiterated their buy rating.
When was the last upgrade for Palvella Therapeutics (PVLA)?
There is no last upgrade for Palvella Therapeutics
When was the last downgrade for Palvella Therapeutics (PVLA)?
There is no last downgrade for Palvella Therapeutics.
When is the next analyst rating going to be posted or updated for Palvella Therapeutics (PVLA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Palvella Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Palvella Therapeutics was filed on April 30, 2025 so you should expect the next rating to be made available sometime around April 30, 2026.
Is the Analyst Rating Palvella Therapeutics (PVLA) correct?
While ratings are subjective and will change, the latest Palvella Therapeutics (PVLA) rating was a reiterated with a price target of $38.00 to $38.00. The current price Palvella Therapeutics (PVLA) is trading at is $22.69, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
